These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2974527)

  • 1. A threshold effect in the induction of tumorigenicity of an established human cell line by v-mos.
    O'Hara BM; Blair DG
    Oncogene; 1988 Sep; 3(3):295-9. PubMed ID: 2974527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of v-mos in transformation, oncogenicity, and metastatic potential of mink lung cells.
    Gao CL; Wang LC; Vass WC; Seth A; Chang KS
    Oncogene; 1988 Sep; 3(3):267-73. PubMed ID: 2849740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ; Marx M; Calothy G; Blair DG
    Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of the mos oncogene family and associated gene products.
    Bold RJ; Hannink M; Donoghue DJ
    Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
    Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
    Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of type C viral expression and cellular karyotype on human B-lymphoblast tumorigenicity in nude mice.
    Steuer AF; Ting RC; Markham PD; Salahuddin Z; Gallo RC
    J Natl Cancer Inst; 1982 Aug; 69(2):435-41. PubMed ID: 6287077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of v-Mos with soluble vimentin in vitro and in transformed cells.
    Bai W; Arlinghaus RB; Singh B
    Oncogene; 1993 Aug; 8(8):2207-12. PubMed ID: 8336943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
    Thomassen DG; Gilmer TM; Annab LA; Barrett JC
    Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of v-mos is correlated with altered differentiation of carcinoma cells.
    Scherdin U; Steffen M; Dietel M; Boecker W; Breindl M; Hölzel F
    Oncogene; 1990 Nov; 5(11):1619-27. PubMed ID: 2148370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. v-mos-transformed cells fail to enter quiescence but growth arrest in G1 following serum withdrawal.
    Rhodes N; Hicks R; Kasenally AB; Innes CL; Paules RS; Propst F
    Exp Cell Res; 1994 Jul; 213(1):210-7. PubMed ID: 8020593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single Glu(62)-to-Lys(62) mutation in the Mos residues of the R7Delta447Gag-tMos protein causes the mutant virus to induce brain lesions.
    Yuen PH; Ryan EA; Devroe E; Wong PK
    Oncogene; 2001 Feb; 20(6):692-703. PubMed ID: 11314003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
    Sergiescu D; Gerfaux J; Joret AM; Chany C
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Muschel RJ; Williams JE; Lowy DR; Liotta LA
    Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
    Somers KD; Murphey MM
    Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
    Taparowsky EJ; Heaney ML; Parsons JT
    Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of V-src gene amplification with the tumorigenic phenotype in a Syrian hamster embryo cell line.
    Gilmer TM; Lamb PW; Oshimura M; Barrett JC
    Cancer Res; 1987 Sep; 47(17):4663-6. PubMed ID: 3040229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells.
    Kang KS; Sun W; Nomata K; Morita I; Cruz A; Liu CJ; Trosko JE; Chang CC
    Mol Carcinog; 1998 Apr; 21(4):225-33. PubMed ID: 9585252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular ras gene activity is required for full neoplastic transformation by the large tumor antigen of SV40.
    Raptis L; Brownell HL; Corbley MJ; Wood KW; Wang D; Haliotis T
    Cell Growth Differ; 1997 Aug; 8(8):891-901. PubMed ID: 9269898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
    Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
    Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.
    Halachmi E; Witz IP
    Cancer Res; 1989 May; 49(9):2383-9. PubMed ID: 2539901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.